01.11.2013 | Erratum
Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
Erschienen in: Clinical Drug Investigation | Ausgabe 11/2013
Einloggen, um Zugang zu erhalten